DiaMedica Therapeutics Announces Closing of $11.8 Million Private Placement
July 01, 2024 05:00 AM Pacific Daylight Time MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic disease, today announced the closing of its previously announced…